CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
between immune cells in the periphery and deep lymphatic system in MS and healthy controls and in MS, changes in responses to a FDA...
Philadelphia, Pennsylvania, United States
A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts:Part A - first in human ...
Phase 1
Philadelphia, Pennsylvania, United States and 14 other locations
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Philadelphia, Pennsylvania, United States and 18 other locations
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Philadelphia, Pennsylvania, United States and 72 other locations
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Philadelphia, Pennsylvania, United States and 20 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Philadelphia, Pennsylvania, United States and 107 other locations
This study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple...
Phase 4
Philadelphia, Pennsylvania, United States and 9 other locations
This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis...
Phase 4
Philadelphia, Pennsylvania, United States and 10 other locations
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...
Phase 3
Philadelphia, Pennsylvania, United States and 118 other locations
This study will examine the effectiveness of a neuromyelitis optics spectrum disorder (NMOSD) specific Acceptance and Commitment Therapy (ACT) interv...
Philadelphia, Pennsylvania, United States
Clinical trials
Research sites
Resources
Legal